
    
      The total study duration per patient will be 58 to 128 days and will include a screening
      period (1 to 28 days), a food interaction investigation period (when applicable; 4 to 11
      days), two 28-day treatment cycles (56 days), an end-of-treatment visit (within 7 days after
      the last SAR245409 administration) and a follow-up visit (within 30 Â± 3 days after the last
      SAR245409 administration).
    
  